Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Aug 04, 2020
|
staff reporter

NEW YORK ─ Luminex said after the close of the market on Tuesday that its second-quarter revenues rose 32 percent year over year, driven by COVID-19-related sales, in line with preliminary revenues reported in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Raises Q4 and 2020 Revenue, Earnings Guidance

  2. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  3. Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents

  4. UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies

  5. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.